Endocrinology, Vol 137, 2286-2292, Copyright © 1996 by Endocrine Society

ARTICLES

Factors regulating insulin-like growth factor-binding protein-3 binding, processing, and potentiation of insulin-like growth factor action

CA Conover, JT Clarkson and LK Bale
Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, Minnesota 55905, USA.

In this study, we investigated the effects of various biochemical and pharmacological agents on insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) cell binding and action in cultured bovine fibroblasts. When cells were preincubated for 48 h with 50 nM recombinant human (rh) IGFBP-3, IGF-I-stimulated [3H]aminoisobutyric acid ([125H]AIB) uptake was enhanced 2- to 3-fold. The addition of cytoskeletal disrupting agents during the preincubation with rhIGFBP-3 did not affect IGFBP-3 potentiation of IGF-I action, nor did a variety of serine, aspartate, and metalloproteinase inhibitors. On the other hand, ammonium chloride and chloroquine, weak bases that neutralize the pH of acidic cell compartments, blocked IGFBP-3 potentiation of IGF-I- stimulated [3H]AIB uptake. Chloroquine and ammonium chloride had no effect alone and did not inhibit IGF-I receptor binding or action in the absence of rhIGFBP-3. Bafilomycin A, a specific inhibitor of ATP- dependent hydrogen ion pumps, also inhibited IGFBP-3 potentiation of IGF-I-stimulated [3H]AIB uptake. Competitive [125I]IGF-I binding and affinity cross-linking experiments suggested structure/function changes in cell-bound IGFBP-3 that were altered in the presence of chloroquine and bafilomycin. Heparin markedly decreased initial IGFBP-3 cell adherence, but could not promote dissociation of IGFBP-3 from cells after the 48-h preincubation. Moreover, heparin did not inhibit IGFBP-3 potentiation of IGF-I action. In summary, these data indicate that IGFBP-3 undergoes specific pH-dependent structural and/or environmental modifications that mediate the enhancing effect of IGFBP-3 on IGF-I action in bovine fibroblasts. They also suggest that IGFBP-3 binding to heparin-like molecules on the cell surface is not directly involved in this process.

This article has been cited by other articles:

				D. K. Tisi, X.-J. Liu, L. J. Wykes, C. D. Skinner, and K. G. Koski Insulin-Like Growth Factor II and Binding Proteins 1 and 3 from Second Trimester Human Amniotic Fluid Are Associated with Infant Birth Weight J. Nutr., July 1, 2005; 135(7): 1667 - 1672. [Abstract] [Full Text] [PDF]

				O. Fletcher, L. Gibson, N. Johnson, D. R. Altmann, J. M.P. Holly, A. Ashworth, J. Peto, and I. d. S. Silva Polymorphisms and Circulating Levels in the Insulin-Like Growth Factor System and Risk of Breast Cancer: A Systematic Review Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 2 - 19. [Abstract] [Full Text] [PDF]

				A. C. Baege, G. L. Disbrow, and R. Schlegel IGFBP-3, a Marker of Cellular Senescence, Is Overexpressed in Human Papillomavirus-Immortalized Cervical Cells and Enhances IGF-1-Induced Mitogenesis J. Virol., June 1, 2004; 78(11): 5720 - 5727. [Abstract] [Full Text] [PDF]

				R. Rajah, K.-W. Lee, and P. Cohen Insulin-like Growth Factor Binding Protein-3 Mediates Tumor Necrosis Factor-{alpha}-induced Apoptosis: Role of Bcl-2 Phosphorylation Cell Growth Differ., April 1, 2002; 13(4): 163 - 171. [Abstract] [Full Text] [PDF]

				D. R. Clemmons Use of Mutagenesis to Probe IGF-Binding Protein Structure/Function Relationships Endocr. Rev., December 1, 2001; 22(6): 800 - 817. [Abstract] [Full Text] [PDF]

				C. A. Conover, L. K. Bale, S. K. Durham, and D. R. Powell Insulin-Like Growth Factor (IGF) Binding Protein-3 Potentiation of IGF Action Is Mediated through the Phosphatidylinositol-3-Kinase Pathway and Is Associated with Alteration in Protein Kinase B/AKT Sensitivity Endocrinology, September 1, 2000; 141(9): 3098 - 3103. [Abstract] [Full Text] [PDF]

				R. C. Baxter Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E967 - E976. [Abstract] [Full Text] [PDF]

				A. Herrler, J. M. Pell, W.R. Allen, H.M. Beier, and F. Stewart Horse Conceptuses Secrete Insulin-Like Growth Factor-Binding Protein 3 Biol Reprod, June 1, 2000; 62(6): 1804 - 1811. [Abstract] [Full Text]

				V. C. Russo, G. Rekaris, N. L. Baker, L. A. Bach, and G. A. Werther Basic Fibroblast Growth Factor Induces Proteolysis of Secreted and Cell Membrane-Associated Insulin-Like Growth Factor Binding Protein-2 in Human Neuroblastoma Cells Endocrinology, July 1, 1999; 140(7): 3082 - 3090. [Abstract] [Full Text]

				S. Manes, M. Llorente, R. A. Lacalle, C. Gomez-Mouton, L. Kremer, E. Mira, and C. Martinez-A The Matrix Metalloproteinase-9 Regulates the Insulin-like Growth Factor-triggered Autocrine Response in DU-145 Carcinoma Cells J. Biol. Chem., March 12, 1999; 274(11): 6935 - 6945. [Abstract] [Full Text] [PDF]

				C. Agarwal, A. Lambert, R. A.S. Chandraratna, E. A. Rorke, and R. L. Eckert Vitamin D Regulates Human Ectocervical Epithelial Cell Proliferation and Insulin-Like Growth Factor-Binding Protein-3 Level Biol Reprod, March 1, 1999; 60(3): 567 - 572. [Abstract] [Full Text]

				P. F. Collett-Solberg, S. E. Nunn, T. B. Gibson, and P. Cohen Identification of Novel High Molecular Weight Insulin-Like Growth Factor-Binding Protein-3 Association Proteins in Human Serum J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2843 - 2848. [Abstract] [Full Text]

				Y. Yamanaka, E. M. Wilson, R. G. Rosenfeld, and Y. Oh Inhibition of Insulin Receptor Activation by Insulin-like Growth Factor Binding Proteins J. Biol. Chem., December 5, 1997; 272(49): 30729 - 30734. [Abstract] [Full Text] [PDF]

				M. Karas, M. Danilenko, D. Fishman, D. LeRoith, J. Levy, and Y. Sharoni Membrane-associated Insulin-like Growth Factor-binding Protein-3 Inhibits Insulin-like Growth Factor-I-induced Insulin-like Growth Factor-I Receptor Signaling in Ishikawa Endometrial Cancer Cells J. Biol. Chem., June 27, 1997; 272(26): 16514 - 16520. [Abstract] [Full Text] [PDF]

				Y. Oh, S. R. Nagalla, Y. Yamanaka, H.-S. Kim, E. Wilson, and R. G. Rosenfeld Synthesis and Characterization of Insulin-like Growth Factor-binding Protein (IGFBP)-7. RECOMBINANT HUMAN mac25 PROTEIN SPECIFICALLY BINDS IGF-I AND -II J. Biol. Chem., November 29, 1996; 271(48): 30322 - 30325. [Abstract] [Full Text] [PDF]